Toll Free: 1-888-928-9744

Sinovac Biotech Ltd. - Product Pipeline Review - 2014

Published: Jul, 2014 | Pages: 41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Sinovac Biotech Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2014', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sinovac Biotech Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Sinovac Biotech Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Sinovac Biotech Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Sinovac Biotech Ltd.'s pipeline products

Reasons to buy

- Evaluate Sinovac Biotech Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Sinovac Biotech Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Sinovac Biotech Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Sinovac Biotech Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sinovac Biotech Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Sinovac Biotech Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sinovac Biotech Ltd. Snapshot 5
Sinovac Biotech Ltd. Overview 5
Key Information 5
Key Facts 5
Sinovac Biotech Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Sinovac Biotech Ltd. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Combination Treatment Modalities 11
Sinovac Biotech Ltd. - Pipeline Products Glance 12
Sinovac Biotech Ltd. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Sinovac Biotech Ltd. - Clinical Stage Pipeline Products 13
Phase I Products/Combination Treatment Modalities 13
Sinovac Biotech Ltd. - Early Stage Pipeline Products 14
IND/CTA Filed Products/Combination Treatment Modalities 14
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Sinovac Biotech Ltd. - Drug Profiles 17
EV-71 Vaccine 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Pneumococcal Polysaccharides Vaccine (23-valent) 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Chickenpox Vaccine 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Influenza Vaccine [H7N9] 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Pneumococcal Conjugate Vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Rubella Vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Coxsackievirus Vaccine [A16] 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Diphtheria + Tetanus + Pertussis (Acellular) Vaccine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Hepatitis B Vaccine 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Hib Vaccine 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Human Rabies Vaccine 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Meningitis Vaccine 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Polio Vaccine 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Rotavirus Vaccine 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Pandemic Influenza Vaccine 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Sinovac Biotech Ltd. - Pipeline Analysis 33
Sinovac Biotech Ltd. - Pipeline Products by Route of Administration 33
Sinovac Biotech Ltd. - Pipeline Products by Molecule Type 34
Sinovac Biotech Ltd. - Recent Pipeline Updates 35
Sinovac Biotech Ltd. - Dormant Projects 38
Sinovac Biotech Ltd. - Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41
List of Tables
Sinovac Biotech Ltd., Key Information 5
Sinovac Biotech Ltd., Key Facts 5
Sinovac Biotech Ltd. - Pipeline by Indication, 2014 8
Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2014 9
Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2014 10
Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2014 11
Sinovac Biotech Ltd. - Pre-Registration, 2014 12
Sinovac Biotech Ltd. - Phase I, 2014 13
Sinovac Biotech Ltd. - IND/CTA Filed, 2014 14
Sinovac Biotech Ltd. - Preclinical, 2014 15
Sinovac Biotech Ltd. - Discovery, 2014 16
Sinovac Biotech Ltd. - Pipeline by Route of Administration, 2014 33
Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2014 34
Sinovac Biotech Ltd. - Recent Pipeline Updates, 2014 35
Sinovac Biotech Ltd. - Dormant Developmental Projects,2014 38
Sinovac Biotech Ltd., Other Locations 39 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify